Before there was Covid-19, there was HIV/AIDS. Caused by an RNA virus similar to coronavirus, HIV/AIDS swept around the globe in the 1980s. Fortunately, the virus was not as easy to catch as Covid-19, but it was fatal to everyone who caught it in those first years of the pandemic. In the decades since, however, science has made great leaps in treating the virus. Although HIV has resisted a cure, HIV medicines can keep the virus under control as a chronic, latent infection. Today, patients with HIV live nearly as long as patients without the infection.
HIV, or human immunodeficiency virus, infects the body’s immune system. The virus attacks a specific type of white blood cell called the CD4 T lymphocyte. Also called “helper” T-cells, CD4 lymphocytes recognize foreign invaders and sound the alarm to the rest of the immune system to go on the attack.
HIV is spread through sexual fluids (either semen or vaginal fluid), blood, and breast milk. In pregnant women, HIV can infect a baby through the placenta or during labor and delivery. However, the overwhelming majority—67% of HIV infections—are sexually transmitted. Unprotected sex is the single greatest risk factor for HIV infection, but other significant risk factors include untreated STIs, intravenous drug use, blood transfusions, and working in occupations that involve potential exposure to other people’s blood.
As an HIV infection progresses, the amount of CD4 T lymphocytes in the bloodstream decreases, weakening the immune system. Eventually, the body loses the ability to fight off infections and tumors, a condition called HIV Acquired Immune Deficiency Syndrome, or HIV/AIDS. Untreated, most HIV infections will progress to AIDS in ten years. Once AIDS develops, most patients who are untreated usually pass away from infections or cancer within two years.
An HIV infection is not curable but can be managed as a chronic illness with medications called antiretroviral drugs. HIV belongs to a family of viruses called retroviruses. These viruses store their genetic information in RNA and use an enzyme called reverse transcriptase to translate this information into DNA. This newly formed DNA then merges with the cell DNA of a different organism to create copies of the virus. Antiretroviral therapy (ART) can target this process and prevent HIV from evolving into AIDS, but it requires a lifelong commitment to daily treatment.
Even when an HIV infection does not progress to AIDS, patients can experience serious complications due to long-term infections or the effects of antiretroviral therapy. Patients with long-term HIV infection may experience some form of neurological problem, cognitive impairment, or dementia (although the incidence of HIV dementia has decreased by almost 50% with the use of treatment). Heart disease, liver disease, and kidney disease are also major complications and some of the leading causes of death in patients with long-term HIV infection.
For all these reasons, prevention is considered the best treatment for HIV and AIDS. While about 38 million people worldwide are infected with HIV, widespread education and active prevention measures have reduced new infections in the United States to less than 39,000 per year.
HIV infection is primarily identified through a blood or saliva test, but a thorough medical history, physical exam, and other tests are necessary to determine the stage of the disease and the appropriate treatment.
HIV infection passes through four stages: primary infection, chronic HIV infection, symptomatic HIV infection, and AIDS. These stages are distinguished primarily by symptoms, opportunistic infections, the amount of virus in the body, and declining levels of CD4 cells in the bloodstream.
In some people, primary infection occurs one to four weeks after exposure to HIV and typically lasts for no longer than two weeks, though it can drag on for a few months in rare cases. Flu-like symptoms may be experienced, including fever, sore throat, headache, muscle pain, joint pain, and swollen lymph nodes.
Primary infection is followed by a long, latent HIV infection that can last for several years. During this period, there are typically no symptoms at all. This is followed by symptomatic HIV infection, when the weakened immune system makes the body more vulnerable to infections. Symptoms may include persistently swollen lymph nodes, fatigue, fever, involuntary weight loss, shingles (a viral infection), yeast infections of the mouth (oral thrush), and pneumonia.
Full-blown AIDS is marked by serious, multiple infections that are usually not found in healthy people. In addition, severe symptoms such as involuntary weight loss, chronic diarrhea, fever, fatigue, weakness, cognitive impairment, and Parkinson’s-like symptoms characterize this last stage of HIV infection.
Blood or saliva tests identify the virus or antibodies, but a thorough blood test is required to determine the stage of the disease. Several measures need to be taken:
Viral load. This test measures the amount of HIV in the blood. Viral load is often the most reliable predictor of HIV/AIDS progression.
Viral drug resistance. This test identifies strains of HIV that are resistant to some antiretroviral drugs.
CD4 cell count. This test measures the blood concentration of CD4 T lymphocytes, the white blood cells the virus infects and kills. The normal count is 500 to 1200 CD4 cells per cubic millimeter of blood. Symptomatic HIV typically occurs when CD4 counts fall below 500, and AIDS occurs when CD4 counts drop below 200.
A thorough physical and history are necessary to get a full picture of the medical situation. Other blood tests, urine tests, or imaging may be necessary to properly diagnose other infections or cancers requiring treatment. Neuropsychological tests may be used to identify any cognitive or emotional impairment.
The primary goal of HIV treatment is to reduce the viral load to undetectable levels and increase CD4 cell counts. This can only be accomplished through antiretroviral medications, though associated infections or cancers will require separate treatments.
A combination of antiretroviral drugs is used at all stages of an HIV infection to reduce the amount of HIV in the body. Called highly active antiretroviral therapy (HAART), combination drug therapy helps prevent HIV from developing into AIDS.
People who are exposed or may be exposed to the virus may also be put on highly active antiretroviral therapy to prevent HIV infection. Pre-exposure prophylaxis (PrEP), intended for people at high risk for infection, involves taking one tablet (Truvada) every day. Post-exposure prophylaxis (PEP), intended for people who may have been exposed to the virus, is a four-week regimen of three antiretroviral drugs.
The best treatment for HIV is to avoid getting or spreading the infection. HIV prevention involves limiting the number of sexual partners, wearing a condom during sex, and using clean needles when taking intravenous (IV) drugs. HIV-negative individuals with active sex lives or risky behaviors should regularly undergo HIV testing. People with an HIV infection should inform partners about their HIV-positive status before having sex. Reducing the viral load in the body also helps prevent the spreading of the infection, so HIV-positive individuals should rigorously adhere to their treatment regimen.
Highly active antiretroviral therapy (HAART) is the foundation of HIV and AIDS treatment. It requires taking two or more drugs every day for a lifetime to prevent HIV from progressing to AIDS. If started early enough, people infected with HIV can enjoy a lifespan nearly equal to that of people without HIV.
Antiretroviral drugs work by attacking the virus at various stages in its lifecycle. Some drugs prevent the virus from making copies of its genetic material. Other drugs interfere with the virus’s ability to attach to or enter CD4 cells. Additionally, certain drugs can prevent the virus from making new viral particles.
Most antiretroviral therapies involve two, three, or more drugs across two or more drug classes. These include
Nucleoside reverse transcriptase inhibitors (NRTIs) such as Viread (tenofovir disoproxil fumarate), Ziagen (abacavir), Epivir (lamivudine), and Emtriva (emtricitabine) interrupt the virus’s ability to form a complete copy of its genetic material by blocking the enzyme (reverse transcriptase) needed to make this copy.
Non-nucleoside reverse transcriptase inhibitors (NNRTIs) such as Sustiva (efavirenz) and Edurant (rilpivirine) interfere with the process the virus uses to create copies of its genetic material.
Protease inhibitors such as Prezista (darunavir), Norvir (ritonavir), and Reyataz (atazanavir) prevent the virus from making proteins that form the building blocks of virus particles.
Integrase inhibitors such as Tivicay (dolutegravir). Isentress (raltegravir), and Vitekta (elvitegravir) prevent the virus from entering CD4 cells.
Fusion inhibitors are a class of drugs with a single representative, Fuzeon (enfuvirtide). This drug prevents viral particles from attaching to CD4 cells, fusing with the cell’s outer membrane, and injecting genetic material into the cell.
CCR5 antagonists are represented by a single drug, Selzentry (maraviroc) blocks the virus’s ability to attach to a molecule called CCR5 on the outside of CD4 cells so that the virus can’t enter.
Post-attachment inhibitors are represented by a single drug, Trogarzo (ibalizumab-uiyk) is a synthetic antibody that attaches to the CD4 receptor and prevents the virus from entering CD4 cells.
Also called a CY3PA inhibitor, Tybost (cobicistat) is prescribed along with antiretroviral drugs to increase their effectiveness. CY3PA inhibitors block the body’s ability to metabolize drugs, increasing the concentration and availability of antiretroviral drugs in the bloodstream.
HIV medications are always used in regimens of two or more drugs at a time. Many factors determine the appropriate individualized antiretroviral therapy regimen: the stage of the infection, viral load, CD4 cell count, the virus’s resistance to drugs, possible side effects, the presence of hepatitis infection, pregnancy, as well as liver or kidney problems. For this reason, there is no “best” medication for HIV, only the most appropriate combination of drugs for a person’s medical situation.
| Drug name | Learn more | See SingleCare price |
|---|---|---|
| Triumeq | triumeq details | Get free coupon |
| Descovy | descovy details | Get free coupon |
| Genvoya | genvoya details | Get free coupon |
| Prezista | prezista details | Get free coupon |
| Norvir | norvir details | Get free coupon |
| Tivicay | tivicay details | Get free coupon |
| Isentress | isentress details | Get free coupon |
| Sustiva | sustiva details | Get free coupon |
| Selzentry | selzentry details | Get free coupon |
| Abacavir | abacavir-sulfate details | Get free coupon |
| Emtricitabine | emtricitabine details | Get free coupon |
| Ritonavir | ritonavir details | Get free coupon |
| Efavirenz | efavirenz details | Get free coupon |
Side effects are possible with all medications. Different drugs have different side effects. This is not a complete list of side effects. The most common problem with HIV/AIDS therapy involves adhering to the drug schedule due to side effects or other drug-related complications. Ask a healthcare provider about any concerns or questions you might have about possible side effects or drug interactions.
A common serious side effect of antiretroviral therapy (ART) is immune reconstitution inflammatory syndrome (IRIS), a condition that occurs in 10% to 25% of HIV/AIDS patients. Usually occurring two weeks to three months after starting therapy, IRIS involves a recovering immune system that produces an exaggerated inflammatory response to latent infections. Like any immune reaction, IRIS is characterized by fever, swollen lymph nodes, and symptoms typical of the underlying infection. IRIS may require hospitalization or discontinuation of antiretroviral therapy.
Otherwise, side effects will vary depending on the type of antiretroviral medication used:
NRTIs can cause side effects such as nausea, vomiting, diarrhea, and headache. Other side effects may include lactic acid buildup, fever, rash, loss of fat tissue around certain parts of the body, increased liver enzymes, nerve damage, and muscle damage.
NNRTIs can affect the central nervous system and cause headache, dizziness, confusion, sleep problems, nightmares, and mood changes. The most common side effects of NNRTIs are rash and liver damage.
Protease inhibitors can cause gastrointestinal side effects, such as nausea, vomiting, and diarrhea. Other common side effects include abnormal cholesterol and lipid levels and abnormal fat distribution.
Integrase inhibitors most commonly cause skin rash, weight gain, insomnia, and gastrointestinal side effects, such as nausea and diarrhea, depending on which integrase inhibitor is being taken.
CCR5 antagonists (Selzentry) can cause skin rash, dizziness, upper respiratory tract infections, cough, and fever. Selzentry can also cause gastrointestinal problems such as gas, abdominal pain, nausea, and bloating.
Fusion inhibitors (Fuzeon) commonly cause infusion site reactions such as redness, swelling, or itching at the site of injection. Other common side effects of Fuzeon include diarrhea, fatigue, and nausea.
Pharmacokinetic enhancers (Tybost) can cause rash, yellowing of the skin (jaundice), nausea, diarrhea, and headache.
is no cure for HIV. The virus can be controlled with antiretroviral drugs, but the treatment regimen can be challenging at times. Managing HIV is a lifelong project. So, the best home treatment for HIV focuses on maintaining overall health and well-being to keep that project on track.
Success with HIV therapy requires sticking to a specific medication schedule. There are many tools you can use to make sure you stay faithful to the pill schedule. Using a daily pill box, setting an alarm clock, posting the pill schedule on a mirror, or using certain smartphone apps can help make sure you don’t miss a dose.
HIV treatment can be an expensive and lifelong project. However, there are many resources that can help HIV patients get the medication they need. If you lack health insurance, your first resource should be the AIDS Drug Assistance Project (ADAP), a federal program that provides funding for uninsured HIV/AIDS patients. The funds are distributed by individual states, so you should contact your state’s Department of Health directly for specific questions. If drugs aren’t available through the ADAP, Harbor Path is one non-profit organization that offers medications at little to no cost. Many brand-name and generic manufacturers also offer antiretroviral drugs for free or at a discounted price to eligible patients.
While living with HIV can be difficult, you don’t have to walk this journey alone. Support groups and counseling are there to help patients get through the ups and downs of living with the disease and coping with the treatment regimen.
HIV is treated with a combination of two or more antiretroviral drugs. The best combination of HIV drugs is determined by the amount of virus in the body, CD4 counts, the virus’s resistance to certain types of drugs, the patient’s overall medical status, and possible side effects that may be experienced.
New HIV medications continue to be developed and tested every year. HIV cannot be completely eradicated by antiretroviral therapy because the virus hibernates in HIV reservoirs in the brain, spleen, lymph nodes, and gut. Eventually, these reservoirs activate and the HIV infection starts anew. A class of drugs called HDAC (histone deacetylase) inhibitors trigger latent HIV to become active. Combined with antiretroviral therapy, this class of drugs may help eliminate both active and latent HIV in one go, effectively clearing the virus from the body.
Two HIV vaccines, Imbokodo and Mosaico, are currently in clinical trials in Africa, Europe, and the Americas.
Patients infected with HIV are typically put on a drug regimen of two, three, or four antiretroviral medications. This “drug cocktail” is necessary because the virus mutates rapidly, quickly developing into drug-resistant strains. When the virus develops resistance to any one of the drugs in the treatment regimen, the other drugs can help keep that strain under control.
The duration of side effects from HIV medications depends on which drug is being taken. Side effects may be mild and go away on their own within days or weeks. However, other side effects can persist for as long as the drug is being taken.
Side effects of HIV medications can be managed depending on the drug being taken and the side effects being experienced. However, there is no “magic bullet” to reduce drug side effects. To help with nausea, your doctor may recommend taking anti-nausea drugs, eating four or five small meals a day instead of three big meals, or avoiding foods that cause stomach or intestinal irritation, such as spicy foods, alcohol, and caffeine. It’s always a good idea to ask your healthcare provider how to manage certain side effects.
HIV can only be treated with antiretroviral medications. Natural treatments will not control the virus or prevent the infection from developing into late-stage HIV infection, or AIDS.
There is some evidence that an HIV infection can be “cured” if antiretroviral therapy begins immediately after exposure to the virus. This type of therapy follows a “hit early and hit hard” strategy. If not treated right away, though, the infection can become too widespread to be completely eradicated.
HIV. Centers for Disease Control and Prevention (CDC)
HIV Disease Current Practice. StatPearls
HIV Fact Sheets. National Institutes of Health (NIH)
HIV/AIDS. World Health Organization (WHO)
Initial Management of Patients with HIV. American Family Physician
Gerardo Sison, Pharm.D., graduated from the University of Florida. He has worked in both community and hospital settings, providing drug information and medication therapy management services. As a medical writer, he hopes to educate and empower patients to better manage their health and navigate their treatment plans.
...Los ahorros en recetas varían según la receta médica y la farmacia, y pueden alcanzar hasta un 80% de descuento sobre el precio en efectivo. Este es un plan de descuento de recetas médicas. NO es un seguro ni un plan de medicamentos de Medicare. El rango de descuentos para las recetas médicas que se brindan bajo este plan, dependerá de la receta y la farmacia donde se adquiera la receta y puede otorgarse hasta un 80% de descuento sobre el precio en efectivo. Usted es el único responsable de pagar sus recetas en la farmacia autorizada al momento que reciba el servicio, sin embargo, tendrá el derecho a un descuento por parte de la farmacia de acuerdo con el Programa de Tarifas de Descuento que negoció previamente. Towers Administrators LLC (que opera como “SingleCare Administrators”) es la organización autorizada del plan de descuento de recetas médicas ubicada en 4510 Cox Road, Suite 11, Glen Allen, VA 23060. SingleCare Services LLC (“SingleCare”) es la comercializadora del plan de descuento de prescripciones médicas que incluye su sitio web www.singlecare.com. Como información adicional se incluye una lista actualizada de farmacias participantes, así como también asistencia para cualquier problema relacionado con este plan de descuento de prescripciones médicas, comunícate de forma gratuita con el Servicio de Atención al Cliente al 844-234-3057, las 24 horas, los 7 días de la semana (excepto los días festivos). Al utilizar la aplicación o la tarjeta de descuento para recetas médicas de SingleCare acepta todos los Términos y Condiciones, para más información visita: https://www.singlecare.com/es/terminos-y-condiciones. Los nombres, logotipos, marcas y otras marcas comerciales de las farmacias son propiedad exclusiva de sus respectivos dueños.
Los artículos del blog no constituyen asesoramiento médico. Su propósito es brindar información general y no sustituyen el asesoramiento, diagnóstico ni tratamiento médico profesional. Si tiene alguna pregunta sobre una afección médica, consulte siempre a su médico u otro profesional de la salud cualificado. Si cree tener una emergencia médica, llame inmediatamente a su médico o al 911.
© 2025 SingleCare Administrators. Todos los derechos reservados
© 2025 SingleCare Administrators. Todos los derechos reservados